Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - agomelatine-citric acid, quantity: 44.739 mg (equivalent: agomelatine, qty mg) - tablet, film coated - excipient ingredients: colloidal anhydrous silica; povidone; sodium stearylfumarate; mannitol; crospovidone; silicified microcrystalline cellulose; magnesium stearate; stearic acid; hypromellose; macrogol 6000; titanium dioxide; purified talc; iron oxide yellow - treatment of major depression in adults including prevention of relapse.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

international animal health products pty ltd - citric acid; sodium ions - oral solution/suspension - citric acid acid-general active 250.0 g/l; sodium ions mineral-sodium active 46.2 g/l - genitourinary system - dog - greyhound | horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | - acidosis | dehydration | diuretic | diuretic, acidifier or alkaliniser | acidification | acidifier | acidifying | acidosis | alkaliniser | bronchodilator | cardiac stimulant | dehydration | diuresis | diuretic | feline struvite urolithias | fluid retention | hepatotoxic drugs | kidney antiseptic | liver damage | methionine treatment | oedema | parturient udder oedema | retention of fluid | saluresis | stimulant - cardiac | struvite urolithiasis | tonus-improving | tying-up | udder oedema | urinary alkalizer | urinary antiseptic | urinary buffer | urinary calculi | urine | urolithiasis | uterine pessaries

Israel - English - Ministry of Health

ferring pharmaceuticals ltd - citric acid anhydrous; magnesium oxide; sodium picosulfate - powder for solution - sodium picosulfate 10 mg; citric acid anhydrous 12 g; magnesium oxide 3.5 g - citric acid - citric acid - to clean the bowel prior to x-ray examination, endoscopy or surgery.

Zimbabwe - English - Medicines Control Authority

group labs s.a pty ltd - citric acid; sodium bicarbonate; sodium carbonate - granule, effervescent; oral - 25mg

Zimbabwe - English - Medicines Control Authority

glaxosmithkline - citric acid; sodium bicarbonate; sodium carbonate - powder; oral - 2.16; 2.29; 0.5 g

Zimbabwe - English - Medicines Control Authority

glaxosmithkline consumer healthcare s.a. (pty) ltd - citric acid; sodium bicarbonate; sodium carbonate - powder, soluble; oral - 2.16; 2.29; 0.50gram

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - citric acid, quantity: 0.72 g; tartaric acid, quantity: 0.89 g; sodium citrate, quantity: 0.63 g; sodium bicarbonate, quantity: 1.76 g - powder, oral - excipient ingredients: saccharin sodium; flavour - relief from the burning pain of cystitis. urinary alkaliniser.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ranvet pty. limited - citric acid; sodium citrate dihydrate - oral solution/suspension - citric acid acid-general active 93.4 g/l; sodium citrate dihydrate mineral-sodium-salt active 280.0 g/l - genitourinary system - dog - greyhound | racing greyhound - diuretic, acidifier or alkaliniser | reduce acidosis | acidification | acidifier | acidifying | acidosis | alkaliniser | bronchodilator | cardiac stimulant | dehydration | diuresis | diuretic | feline struvite urolithias | fluid retention | hepatotoxic drugs | kidney antiseptic | liver damage | methionine treatment | oedema | parturient udder oedema | retention of fluid | saluresis | stimulant - cardiac | struvite urolithiasis | tonus-improving | tying-up | udder oedema | urinary alkalizer | urinary antiseptic | urinary buffer | urinary calculi | urine | urolithiasis | uterine pessaries

Malta - English - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - citric acid, sodium carbonate, anhydrous, sodium citrate, dihydrate, sodium hydrogen - granules for oral solution - citric acid 1063 mg sodium carbonate anhydrous 130 mg sodium citrate dihydrate 2819 mg sodium hydrogen carbonate 1200 mg - urologicals

United States - English - NLM (National Library of Medicine)

ferring pharmaceuticals inc. - sodium picosulfate (unii: lr57574hn8) (deacetylbisacodyl - unii:r09078e41y), magnesium oxide (unii: 3a3u0gi71g) (magnesium cation - unii:t6v3lhy838), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - sodium picosulfate 10 mg in 16.1 g - prepopik® is indicated for cleansing of the colon as a preparation for colonoscopy in adults and pediatric patients 9 years of age and older. prepopik is contraindicated in the following conditions: - patients with severe renal impairment (creatinine clearance less than 30 ml/minute) which may result in accumulation of magnesium [see warnings and precautions (5.4)] - gastrointestinal obstruction or ileus [see warnings and precautions (5.6)] - bowel perforation [see warnings and precautions (5.6)] - toxic colitis or toxic megacolon - gastric retention - hypersensitivity to any of the ingredients in prepopik [see adverse reactions (6.2)] risk summary there are no data with prepopik use in pregnant women to determine a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. in an animal reproduction study, no adverse developmental effects were observed in pregnant rats when sodium picosulfate, magnesium oxide, and anhydrous citric acid were administered orally at doses 1